NIOX Group (NIOX) Competitors

Smith & Nephew (LON:SN) and NIOX Group (LON:NIOX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Is SN or NIOX a better dividend stock?

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.6%. NIOX Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.5%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 4,126.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew is clearly the better dividend stock, given its higher yield and lower payout ratio.

Does the media refer more to SN or NIOX?

In the previous week, Smith & Nephew had 1 more articles in the media than NIOX Group. MarketBeat recorded 1 mentions for Smith & Nephew and 0 mentions for NIOX Group. Smith & Nephew's average media sentiment score of 1.16 beat NIOX Group's score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the media.

Company	Overall Sentiment
Smith & Nephew	Positive
NIOX Group	Neutral

Does the MarketBeat Community favor SN or NIOX?

Smith & Nephew received 557 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 62.02% of users gave Smith & Nephew an outperform vote.

Company	Underperform	Outperform
Smith & Nephew	Outperform Votes 560 62.02%	Underperform Votes 343 37.98%
NIOX Group	Outperform Votes 3 100.00%	Underperform Votes No Votes

Do analysts rate SN or NIOX?

Smith & Nephew currently has a consensus target price of GBX 7,840, indicating a potential upside of 599.69%. NIOX Group has a consensus target price of GBX 90, indicating a potential upside of 33.53%. Given Smith & Nephew's higher possible upside, research analysts clearly believe Smith & Nephew is more favorable than NIOX Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
NIOX Group	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders believe in SN or NIOX?

62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 35.2% of NIOX Group shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by insiders. Comparatively, 46.7% of NIOX Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has more risk & volatility, SN or NIOX?

Smith & Nephew has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.

Is SN or NIOX more profitable?

NIOX Group has a net margin of 28.21% compared to Smith & Nephew's net margin of 5.41%. NIOX Group's return on equity of 13.29% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew	5.41%	5.85%	4.51%
NIOX Group	28.21%	13.29%	3.95%

Which has better valuation & earnings, SN or NIOX?

NIOX Group has lower revenue, but higher earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew	£7.08B	1.73	£382.79M	£27.77	40.34
NIOX Group	£3.53B	7.84	£995.88M	£0.02	2,781.48

Summary

Smith & Nephew beats NIOX Group on 10 of the 18 factors compared between the two stocks.